Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gynecologic Oncology
•
Palliation
•
Medical Oncology
•
Supportive Care
How would you manage a patient with FIGO stage IIIB endometrial carcinoma who developed significant back pain with Carboplatin/Paclitaxel cycle 1, which worsened during cycle 2?
Related Questions
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
What does bevacizumab contribute in metastatic cervical cancer when used in combination with a platinum doublet + pembrolizumab?
When do you recommend adjuvant trastuzumab for completely resected uterine cancer and for how long do you give it?
What are your top takeaways from SGO 2025?
How do you best incorporate use of filgrastim/pegfilgrastim in capecitabine based regimens?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?
How would you manage concurrent immunotherapy-related colitis and C. difficile infection?
Does an allergy to the platinum metal, with moderate reaction to platinum inhaled particles, confer allergy to platinum-based chemotherapy?
Do you have concerns about the validity of the INTERLACE data, considering the long study recruitment period (10 years) and evolution of radiation techniques that have occurred during that time frame?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
